GLOBE PHARMA ApS: Financial statements 2019
CVR: 36493119
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
GLOBE PHARMA ApS (CVR 36493119) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 694,779 and a net result of DKK 515,897 compared with DKK 546,994 the year before. That is a decrease of 4.2% compared with the year before. Equity in the 2019 report amounted to DKK 566,333. The solvency ratio was 27.8%.
- Gross Profit
- DKK 694,779
- Profit/Loss
- DKK 515,897
- Equity
- DKK 566,333
- Total Assets
- DKK 2,038,396
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 695 t. | 516 t. | 566 t. | - |
| 2018 | - | 725 t. | 547 t. | 597 t. | - |
| 2017 | - | 677 t. | 513 t. | 296 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout GLOBE PHARMA ApS
GLOBE PHARMA ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Ravn. The company is owned by RAVNEN HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,623,545 and a net result of DKK 460,318 compared with DKK 738,896 the year before. Equity in the 2025 report amounted to DKK 511,882.